INSIGHTEC Investment Update

The innovator of MR-guided focused ultrasound is scaling to meet the growing demand for incisionless surgery

HAIFA, Israel and MIAMI, March 6, 2020 / INSIGHTEC, a commercial-stage medical technology company, announced today the signing of definitive agreements for a Series F investment round of up to $150 million at a post-money valuation of $1.3 billion. Koch Disruptive Technologies (KDT), a subsidiary of Koch Industries focused on finding and funding innovative and emerging companies, is leading the round and has committed to invest $100 million at an initial closing to follow shareholder approval. This is KDT’s second direct investment in INSIGHTEC.

Continue reading…

Cameron Gawley

Cameron Gawley

CEO & Co-Founder

More To Explore